100 Clinical Results associated with Delaware Institute For Reproductive Medicine LLC
0 Patents (Medical) associated with Delaware Institute For Reproductive Medicine LLC
01 Feb 2000·Delaware medical journal
Dalteparin sodium injection treatment in patients with immunologic recurrent pregnancy loss.
Article
Author: Trott, A M ; Trott, E A
Dalteparin sodium injection in patients with an immunologic component to RPL resulted in an increase in compliance without any adverse early pregnancy outcomes.
The Eugin Group, part of Fresenius Helios, acquires a majority stake in the Delaware Institute for Reproductive Medicine (DIRM), a renowned fertility center in the U.S. state of Delaware that has been established for 35 years. With this acquisition, Eugin further expands its existing network in the U.S. and expects to generate additional synergies and operational efficiencies. A number of key physicians will remain minority shareholders in DIRM. Both sides have agreed not to disclose financial details.
100 Deals associated with Delaware Institute For Reproductive Medicine LLC
100 Translational Medicine associated with Delaware Institute For Reproductive Medicine LLC